JP2025520600A5 - - Google Patents

Info

Publication number
JP2025520600A5
JP2025520600A5 JP2024574752A JP2024574752A JP2025520600A5 JP 2025520600 A5 JP2025520600 A5 JP 2025520600A5 JP 2024574752 A JP2024574752 A JP 2024574752A JP 2024574752 A JP2024574752 A JP 2024574752A JP 2025520600 A5 JP2025520600 A5 JP 2025520600A5
Authority
JP
Japan
Prior art keywords
kit
level
subject
endometriosis
fluid sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024574752A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025520600A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/067108 external-priority patent/WO2023247752A1/en
Publication of JP2025520600A publication Critical patent/JP2025520600A/ja
Publication of JP2025520600A5 publication Critical patent/JP2025520600A5/ja
Pending legal-status Critical Current

Links

JP2024574752A 2022-06-23 2023-06-23 子宮内膜症を診断するためおよび子宮内膜症の病期を分類するための方法 Pending JP2025520600A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22180800.9 2022-06-23
EP22180800 2022-06-23
PCT/EP2023/067108 WO2023247752A1 (en) 2022-06-23 2023-06-23 Method for diagnosing endometriosis and for classifying the stage of endometriosis

Publications (2)

Publication Number Publication Date
JP2025520600A JP2025520600A (ja) 2025-07-03
JP2025520600A5 true JP2025520600A5 (https=) 2026-03-13

Family

ID=82258417

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024574752A Pending JP2025520600A (ja) 2022-06-23 2023-06-23 子宮内膜症を診断するためおよび子宮内膜症の病期を分類するための方法

Country Status (5)

Country Link
US (1) US20250130244A1 (https=)
EP (1) EP4544305A1 (https=)
JP (1) JP2025520600A (https=)
CN (1) CN119404103A (https=)
WO (1) WO2023247752A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025024616A1 (en) * 2023-07-24 2025-01-30 Dot Laboratories, Inc. Artificial intelligence methods and systems for determining endometriosis status

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342606A (en) 1984-10-18 1994-08-30 Board Of Regents, The University Of Texas System Polyazamacrocyclic compounds for complexation of metal ions
US5316757A (en) 1984-10-18 1994-05-31 Board Of Regents, The University Of Texas System Synthesis of polyazamacrocycles with more than one type of side-chain chelating groups
US5221605A (en) 1984-10-31 1993-06-22 Igen, Inc. Luminescent metal chelate labels and means for detection
US5591581A (en) 1986-04-30 1997-01-07 Igen, Inc. Electrochemiluminescent rhenium moieties and methods for their use
JPH0737464B2 (ja) 1986-04-30 1995-04-26 イゲン，インコーポレーテッド エレクトロ化学ルミネセンスアツセイ
JPH076913B2 (ja) 1988-11-03 1995-01-30 イゲン，インコーポレーテッド アミン誘導還元剤を利用する電気化学発光反応
ZA898290B (en) 1988-11-03 1991-06-26 Igen Inc Electrochemiluminescent assays
IL100867A (en) 1991-02-06 1995-12-08 Igen Inc Method and apparatus for improved luminescence assays
US5739294A (en) 1991-12-10 1998-04-14 The Dow Chemical Company Bicyclopol yazamacrocyclophosphonic acid complexes for use as contrast agents
US5480990A (en) 1991-12-10 1996-01-02 The Dow Chemical Company Bicyclopolyazamacrocyclocarboxylic acid complexes for use as contrast agents
US5428139A (en) 1991-12-10 1995-06-27 The Dow Chemical Company Bicyclopolyazamacrocyclophosphonic acid complexes for use as radiopharmaceuticals
ZA929351B (en) 1991-12-11 1993-06-04 Igen Inc Electrochemiluminescent label for DNA assays.
US5385893A (en) 1993-05-06 1995-01-31 The Dow Chemical Company Tricyclopolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
US5462725A (en) 1993-05-06 1995-10-31 The Dow Chemical Company 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
US5834461A (en) 1993-07-29 1998-11-10 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
CA2172248C (en) 1993-09-22 2003-12-30 John Kenten Self-sustained sequence replication electrochemiluminescent nucleic acid assay
US5786141A (en) 1994-08-26 1998-07-28 Bard; Allen J. Electrogenerated chemiluminescence labels for analysis and/or referencing
JPH10509025A (ja) 1994-08-26 1998-09-08 アイジェン， インコーポレイテッド 固体表面に吸着された核酸の電気的に発生した化学ルミネッセンス性検出のためのバイオセンサーおよび方法
US5643713A (en) 1995-06-07 1997-07-01 Liang; Pam Electrochemiluminescent monitoring of compounds
US6852502B1 (en) 1995-06-06 2005-02-08 Bioveris Corporation Electrochemiluminescent enzyme biosensors
WO1996033411A1 (en) 1995-04-18 1996-10-24 Igen, Inc. Electrochemiluminescence of rare earth metal chelates
US5679519A (en) 1995-05-09 1997-10-21 Oprandy; John J. Multi-label complex for enhanced sensitivity in electrochemiluminescence assay
CA2223027A1 (en) 1995-06-07 1996-12-19 Igen, Inc. Electrochemiluminescent enzyme immunoassay
US20050106667A1 (en) 2003-08-01 2005-05-19 Genentech, Inc Binding polypeptides with restricted diversity sequences
US8367332B2 (en) 2008-10-31 2013-02-05 Case Western Reserve University Detection and quantification of abasic site formation in vivo
CN103347888B (zh) 2011-02-09 2016-12-21 霍夫曼-拉罗奇有限公司 用于ecl的新的基于铱的复合物
TW201401798A (zh) 2012-06-28 2014-01-01 Chunghwa Telecom Co Ltd ＦＴＴｘ光終端設備之用戶端動態多路由饋電系統
WO2014091580A1 (ja) 2012-12-12 2014-06-19 株式会社東芝 クラウドシステム管理装置、クラウドシステム、再配置方法、及びプログラム
JP5922639B2 (ja) 2013-12-07 2016-05-24 レノボ・シンガポール・プライベート・リミテッド 折り畳み式の電子機器、表示システム、および表示方法
US9716942B2 (en) 2015-12-22 2017-07-25 Bose Corporation Mitigating effects of cavity resonance in speakers
EP4004555A1 (en) * 2019-07-22 2022-06-01 F. Hoffmann-La Roche AG S100a6 as blood biomarker for the non-invasive diagnosis of endometriosis
WO2022207628A1 (en) * 2021-03-30 2022-10-06 F. Hoffmann-La Roche Ag Scf as blood biomarker for the non-invasive diagnosis of endometriosis

Similar Documents

Publication Publication Date Title
Reilly et al. Acute respiratory distress syndrome phenotypes
Sarma et al. Biomarkers and precision medicine: state of the art
JP2009535644A (ja) バイオマーカーを使用して疾患状況を同定するための方法および装置
TELLADO et al. Predicting mortality based on body composition analysis
CN101175998A (zh) 使用生化标志的肝脂肪变性诊断方法
CN118658629B (zh) 基于智慧医疗的冠心病风险辅助评估系统
EP4493711A1 (en) Method of monitoring cancer using fragmentation profiles
JP2025520600A5 (https=)
CN117683849A (zh) 一种心力衰竭的生物标志物及其应用
RU2583939C1 (ru) Способ лабораторной диагностики стадии фиброза печени при хроническом вирусном гепатите с
CN118430784A (zh) Chb合并hs的进展期纤维化和肝硬化的诊断系统及其构建方法
Hynes et al. Arteriovenous blood gas agreement in intensive care patients with varying levels of circulatory compromise: a pilot study
US8630808B2 (en) Estimation of diagnostic markers
CN116355983A (zh) 用于评估受试者免疫年龄的方法、组合物和系统
CN118866120B (zh) 预测脓毒症患者死亡高风险的生物标志物、系统及其应用
CN120748732A (zh) 一种基于血流感染发生时点的重症患者器官衰竭评估与风险分层方法
Stachon et al. Estimation of the mortality risk of surgical intensive care patients based on routine laboratory parameters
CN114941031B (zh) 早期胃癌预后差异基因与复发预测模型
CN116030986A (zh) 心脏外科术后谵妄风险预测模型、方法和电子设备
Geifmanª¹ et al. Patient Stratification Using Longitudinal Data-Application of Latent Class Mixed Models
CN118806773B (zh) Udca系列胆汁酸在预防脓毒症肠道炎症损伤中的作用机制及其应用
US20240003904A1 (en) Biomarker-based risk model to predict persistent multiple organ dysfunction after congenital heart surgery
RU2760095C1 (ru) Способ количественной оценки агрегационной активности тромбоцитов у пациентов с новой коронавирусной инфекцией
Varma A small step in the right direction
Mackenzie Predicting concordance of biochemical lung maturity in the preterm twin gestation